ATE283917T1 - Agouti verwandtes gen - Google Patents

Agouti verwandtes gen

Info

Publication number
ATE283917T1
ATE283917T1 AT97918802T AT97918802T ATE283917T1 AT E283917 T1 ATE283917 T1 AT E283917T1 AT 97918802 T AT97918802 T AT 97918802T AT 97918802 T AT97918802 T AT 97918802T AT E283917 T1 ATE283917 T1 AT E283917T1
Authority
AT
Austria
Prior art keywords
art
gen
disclosed
agouti related
adrenal
Prior art date
Application number
AT97918802T
Other languages
English (en)
Inventor
Kevin Lee Stark
Roland Luethy
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE283917T1 publication Critical patent/ATE283917T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
AT97918802T 1996-05-10 1997-04-22 Agouti verwandtes gen ATE283917T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (1)

Publication Number Publication Date
ATE283917T1 true ATE283917T1 (de) 2004-12-15

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918802T ATE283917T1 (de) 1996-05-10 1997-04-22 Agouti verwandtes gen

Country Status (12)

Country Link
US (5) US5766877A (de)
EP (1) EP0917571B1 (de)
JP (1) JP4219404B2 (de)
AT (1) ATE283917T1 (de)
AU (1) AU2681497A (de)
CA (1) CA2253238C (de)
DE (1) DE69731834T2 (de)
DK (1) DK0917571T3 (de)
ES (1) ES2234015T3 (de)
PT (1) PT917571E (de)
SI (1) SI0917571T1 (de)
WO (1) WO1997043412A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843652A (en) * 1993-05-21 1998-12-01 Lockheed Martin Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
WO2002064091A2 (en) * 2001-02-13 2002-08-22 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
EP0942967A1 (de) * 1996-11-06 1999-09-22 Children's Medical Center Corporation Transgene-tier, das einen syndecan in den gebieten des hypothalamus exprimiert
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
ATE367581T1 (de) * 1997-12-16 2007-08-15 Merck & Co Inc C-TERMINALE REGION DES ßAGOUTI-RELATED- TRANSCRIPTß-PROTEINS (ART)
AU3964499A (en) * 1998-03-30 1999-10-18 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
JP2002524724A (ja) * 1998-09-03 2002-08-06 ミレニアム ファーマシューティカルズ インク． 薬物中毒を治療するために用いられる化合物を同定する際の標的としてのｍｃ４−ｒ
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6716810B1 (en) 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6303749B1 (en) * 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (de) 2000-01-18 2003-01-02 Pfizer Products Inc. Verwendungen von AGRP-Melanocortinrezeptorbindung modulierenden Verbindungen
JP2003535190A (ja) * 2000-05-31 2003-11-25 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー オレフィンの重合
DE60216747T2 (de) * 2001-04-09 2007-10-04 Novartis Vaccines and Diagnostics, Inc., Emeryville Guanidinoverbindungen als melanocortin-4-rezeptor (mc4-r) agonisten
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
EP1487474A4 (de) * 2002-02-25 2006-11-29 Chiron Corp Intranasale verabreichung von mc4-r agonisten
US7034033B2 (en) * 2002-05-23 2006-04-25 Chiron Corporation Substituted quinazolinone compounds
CA2488725A1 (en) * 2002-07-03 2004-01-15 Su Qian Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
JP2007501861A (ja) * 2003-05-23 2007-02-01 カイロン コーポレイション Ｍｃ４−ｒアゴニストとしてのグアニジノ置換キナゾリノン化合物
JP2007501622A (ja) * 2003-08-13 2007-02-01 サンド・アクチエンゲゼルシヤフト 組換えポリペプチドを精製するための方法
KR20060105785A (ko) * 2003-11-19 2006-10-11 카이론 코포레이션 감소된 생체축적을 갖는 퀴나졸리논 화합물
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
BRPI0510095A (pt) * 2004-04-20 2007-10-16 Transtech Pharma Inc tiazol substituìdo e derivados de pirimidina como moduladores de receptores de melanocortina
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
WO2010025142A1 (en) * 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
US9018395B2 (en) 2011-01-27 2015-04-28 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
EP0052322B1 (de) * 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
EP0143949B1 (de) * 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmazeutische Zusammensetzung mit Gehalt an Urokinase
EP0154316B1 (de) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemisch modifizierte Lymphokine und Verfahren zu ihrer Herstellung
CA2006596C (en) * 1988-12-22 2000-09-05 Rika Ishikawa Chemically-modified g-csf
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Also Published As

Publication number Publication date
SI0917571T1 (en) 2005-06-30
DE69731834D1 (de) 2005-01-05
US6060589A (en) 2000-05-09
CA2253238C (en) 2008-08-12
EP0917571B1 (de) 2004-12-01
US20030082737A1 (en) 2003-05-01
JP4219404B2 (ja) 2009-02-04
US20010007752A1 (en) 2001-07-12
US7122520B2 (en) 2006-10-17
DE69731834T2 (de) 2005-12-15
ES2234015T3 (es) 2005-06-16
DK0917571T3 (da) 2005-03-14
JP2001517931A (ja) 2001-10-09
US5766877A (en) 1998-06-16
US6203995B1 (en) 2001-03-20
WO1997043412A1 (en) 1997-11-20
EP0917571A1 (de) 1999-05-26
PT917571E (pt) 2005-04-29
CA2253238A1 (en) 1997-11-20
AU2681497A (en) 1997-12-05

Similar Documents

Publication Publication Date Title
DE69731834D1 (de) Agouti verwandtes gen
ZA967173B (en) Purified coprinus laccases and nucleic acids and encoding same
WO2001018172A3 (en) Fibroblast growth factor-like polypeptides
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
WO2002031134A3 (en) Novel serine protease genes related to dppiv
WO2000073348A3 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
AU3802595A (en) Tripeptidyl aminopeptidase
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
HUP9904414A2 (hu) A neuritin neurogén
WO1997027276A3 (en) Nucleic acids encoding polypeptides having absidia lipase activity
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
DE69934017D1 (de) 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung
WO2000041509A3 (en) Polypeptides having acid phosphatase activity and nucleic acids encoding same
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
CA2390685A1 (en) Methods and compositions for inhibiting neoplastic cell growth
ATE273391T1 (de) Neurotrophischer faktor nnt-1
AU1526099A (en) Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
WO1999050288A3 (en) Mammalian blood loss-induced gene, kd312

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0917571

Country of ref document: EP

REN Ceased due to non-payment of the annual fee